Jeffrey P. George insider trades
Open-market stock purchases and sales by Jeffrey P. George, Director at LENZ Therapeutics, Inc, from SEC Form 4 filings since Dec 14, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -64%.